Resmed (RSMDF) Non-Current Assets (2010 - 2026)
Resmed's (RSMDF) quarterly Non-Current Assets came in at $4.6 billion in Q2 2026, down 0.59% on a YoY basis from $4.7 billion in Q2 2025, and down 1.67% quarter-over-quarter from $4.7 billion in Q1 2026.
Analysis
Resmed (RSMDF) Non-Current Assets (2010 - 2026) Analysis & Trends
Resmed (RSMDF) has reported Non-Current Assets for 17 consecutive years, with $4.6 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets fell 0.59% year-over-year to $4.6 billion; the trailing twelve-month figure through Jun 2026 stood at $4.6 billion (down 0.59% YoY), and the FY2026 full-year result was $4.6 billion, down 0.59% from the prior year.
- Non-Current Assets eased to $4.6 billion in Q2 2026 per RSMDF's latest filing, from $4.7 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $4.7 billion in Q1 2026 and bottomed at $3.1 billion in Q3 2022.
- Historically, Non-Current Assets has averaged $4.3 billion across 5 years, with a median of $4.4 billion in 2023.
- The sharpest annual moves came in 2023 and 2024: Non-Current Assets soared 41.11% in 2023, then decreased 4.9% in 2024.
- Over 5 years, Non-Current Assets stood at $4.4 billion in 2022, then grew by 4.05% to $4.5 billion in 2023, then dropped by 4.9% to $4.3 billion in 2024, then grew by 8.81% to $4.7 billion in 2025, then retreated by 0.93% to $4.6 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $4.6 billion, $4.7 billion, and $4.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 4.64 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.64 Bn |
| Mar 31, 2026 | 4.72 Bn |
| Dec 31, 2025 | 4.68 Bn |
| Sep 30, 2025 | 4.68 Bn |
| Jun 30, 2025 | 4.67 Bn |
| Mar 31, 2025 | 4.36 Bn |
| Dec 31, 2024 | 4.31 Bn |
| Sep 30, 2024 | 4.58 Bn |
| Jun 30, 2024 | 4.51 Bn |
| Mar 31, 2024 | 4.46 Bn |
| Dec 31, 2023 | 4.53 Bn |
| Sep 30, 2023 | 4.44 Bn |
| Jun 30, 2023 | 4.38 Bn |
| Mar 31, 2023 | 4.38 Bn |
| Dec 31, 2022 | 4.35 Bn |
| Sep 30, 2022 | 3.14 Bn |
| Jun 30, 2022 | 3.16 Bn |
| Mar 31, 2022 | 3.20 Bn |
| Dec 31, 2021 | 3.19 Bn |
| Sep 30, 2021 | 3.14 Bn |